Overview of the Global Dry Eye Syndrome Industry:
The Global Dry Eye Syndrome market is projected to experience substantial growth between 2024 and 2030, driven by digital transformation, innovation in service delivery, and expanding global demand. With a forecasted CAGR of 4.21% during the forecast period, i.e., 2024–30. This report offers an in-depth analysis of the key drivers, challenges, competitive landscape, and future outlook — helping businesses, investors, and stakeholders make informed decisions.
Market Size & Forecast (2024–2030)
- Base Year: 2023
- Forecast Period: 2024–2030
- Estimated CAGR (2024–2030): 4.21%
Key Market Driver (What’s Driving Dry Eye Syndrome Sector Growth?)
Growing Number of Eye Care Centers Prompting Surge in Product Utilization – The prevalence of dry eye disease has been increasing worldwide, owing to various reasons such as environmental conditions, hormonal changes, a rise in the geriatric population, autoimmune disorders, etc. This has resulted in a spike in eye clinics & centers globally for treatment. Additionally, the blossoming of eye care centers is majorly driven by the steady boost in professionals, such as ophthalmologists & optometrists. While the number of ophthalmologists is expected to remain stable, the number of optometrists is presumed to raise.
Optometrists offer services through private practices, chain/mass merchandisers, and government organizations. Independent optometrists can differentiate themselves by providing personalized care, building patient loyalty, and offering clinical care. Hence, this allows them to offer a higher level of service to the patients. Thus, the growing number of eye care centers is prompting a surge in product utilization of DED & would propel its demand in the forecast years.
In case you missed it, we are currently revising our reports. Click on the “request sample report“ button to get the latest research data with forecast for the years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.
(“Engage with our team using your official business email to unlock full access and priority support.”)
Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/dry-eye-disease-drugs-market.html
Global Dry Eye Syndrome Industry Recent Development:
- 2023: Novaliq & Bosch+Laumb announced the publication of pivotal phase 3 data of their ophthalmic drug NOVO3, which is developed to treat the signs & symptoms of Dry Eye Disease associated with meibomian gland dysfunction.
- 2022: Santen Pharmaceutical launched its dry-eye treatment DIQUAS® LX Ophthalmic Solution in Japan, which is an improved formulation to reduce administration frequency to three times daily & ease the patient burden.
Top Companies in the Dry Eye Syndrome Market
Here’s a snapshot of key players leading innovation and market share:
- Mitotech Pharma
- ReGen Tree
- Santen Pharmaceutical
- HanAll BioPharma
- Sun Pharma
- Novaliq
- Sylentis
- Alcon
- Horus Pharma
- Johnson & Johnson
- Alderya Therapeutics
- Visufarma
- Allergan
- Prestige Consumer Health
- Others
Includes SWOT analysis, revenue trends, partnerships, and product launches.
Factor Hinder Dry Eye Syndrome Industry Growth
Availability of Alternative Therapies – The presence of alternative therapies, such as nutritional supplements, acupuncture, etc., to treat dry eye disease is a significant challenge for the Dry Eye Syndrome Market. These therapies garnered attention owing to their natural & holistic nature of treatment among patients. This can make it tough for dry eye disease drugs to gain market share, especially if patients prefer alternative therapies as they are not aware of the benefits of prescribed medications. Hence, the presence of alternative therapies limits the adoption of the prescribed drug & hampers the market progression.
Explore Our Comprehensive Study: https://www.marknteladvisors.com/research-library/dry-eye-disease-drugs-market.html
Dry Eye Syndrome Market Segmentation Analysis
-By Product
- Artificial Tears
- Anti-inflammatory Drugs
- Punctal Plugs
Anti-inflammatory drugs are among the most prevailing treatments for dry eye disease & have a high contribution in expanding the market size, hence driving the market growth.
-By Distribution Channel
- Offline
- Online
The Offline segment held a significant share of the Global Dry Eye Disease Market. Hospital Pharmacies serve a large population of patients, which leads to an upsurge in demand for effective treatments from this category.
-By Disease Type
- Aqueous Dry Eye – Market Size & Forecast 2019-2030, USD Million
- Evaporative Dry Eye – Market Size & Forecast 2019-2030, USD Million
-By Competition
- Competition Characteristics
- Market Share Analysis
Geographical Analysis
-By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
North American region depicts considerable growth in the market, as the region captured the major share of the Dry Eye Syndrome Market owing to a large patient pool, increasing per capita healthcare expenditure, and soaring investment, merger, and acquisition of key players across the region.
Contact Our Analysts for Brochure Requests, Customization, or Any Pre-Purchase Inquiries: https://www.marknteladvisors.com/query/request-customization/dry-eye-disease-drugs-market.html
Methodology Behind the Report
This research combines qualitative and quantitative methods, including:
- Expert interviews
- Proprietary forecasting models
- Financial and trade databases
- Government and institutional data
Forecasts are validated using top-down and bottom-up approaches to ensure accuracy and reliability.
Frequently Asked Questions About the Dry Eye Syndrome Market
- What is the growth rate of the Dry Eye Syndrome market from 2024–2030?
- Which segment are expected to dominate market?
- Who are the top companies and what strategies being they using?
- What are the key risks and challenges in this industry?
- How can businesses prepare for future trends?
About Us –
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
We have our existence across the market for many years and have conducted multi-industry research across 14.50+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.
Media Contact:
Company Name: MarkNtel Advisors
Email: sales@marknteladvisors.com
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, India
